Chen CS - Search Results

1

Combination antiangiogenic therapy and radiation in head and neck cancers.

Hsu HW, Wall NR, Hsueh CT, Kim S, Ferris RL, Chen CS, Mirshahidi S. Hsu HW, et al. Among authors: chen cs. Oral Oncol. 2014 Jan;50(1):19-26. doi: 10.1016/j.oraloncology.2013.10.003. Epub 2013 Oct 23. Oral Oncol. 2014. PMID: 24269532 Review.

2

Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Bautista MA, Stevens WT, Chen CS, Curtis BR, Aster RH, Hsueh CT. Bautista MA, et al. Among authors: chen cs. J Hematol Oncol. 2010 Mar 26;3:12. doi: 10.1186/1756-8722-3-12. J Hematol Oncol. 2010. PMID: 20346128 Free PMC article. Review.

3

Linifanib (ABT-869) enhances radiosensitivity of head and neck squamous cell carcinoma cells.

Hsu HW, Gridley DS, Kim PD, Hu S, de Necochea-Campion R, Ferris RL, Chen CS, Mirshahidi S. Hsu HW, et al. Among authors: chen cs. Oral Oncol. 2013 Jun;49(6):591-7. doi: 10.1016/j.oraloncology.2013.02.009. Epub 2013 Mar 13. Oral Oncol. 2013. PMID: 23490884

4

Clinico-pathologic relevance of Survivin splice variant expression in cancer.

Necochea-Campion Rd, Chen CS, Mirshahidi S, Howard FD, Wall NR. Necochea-Campion Rd, et al. Among authors: chen cs. Cancer Lett. 2013 Oct 10;339(2):167-74. doi: 10.1016/j.canlet.2013.06.007. Epub 2013 Jun 18. Cancer Lett. 2013. PMID: 23791888 Free PMC article. Review.

5

Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells.

Hsu HW, de Necochea-Campion R, Williams V, Duerksen-Hughes PJ, Simental AA Jr, Ferris RL, Chen CS, Mirshahidi S. Hsu HW, et al. Among authors: chen cs. Oral Oncol. 2014 Jul;50(7):662-9. doi: 10.1016/j.oraloncology.2014.03.006. Epub 2014 Apr 13. Oral Oncol. 2014. PMID: 24735547

6

Down-regulation of LXR/RXR activation and negative acute phase response pathways in colon adenocarcinoma revealed by proteomics and bioinformatics analysis.

Tang H, Mirshahidi S, Senthil M, Kazanjian K, Chen CS, Zhang K. Tang H, et al. Among authors: chen cs. Cancer Biomark. 2014;14(5):313-24. doi: 10.3233/CBM-140409. Cancer Biomark. 2014. PMID: 25171473

7

AML sensitivity to YM155 is modulated through AKT and Mcl-1.

de Necochea-Campion R, Diaz Osterman CJ, Hsu HW, Fan J, Mirshahidi S, Wall NR, Chen CS. de Necochea-Campion R, et al. Among authors: chen cs. Cancer Lett. 2015 Sep 28;366(1):44-51. doi: 10.1016/j.canlet.2015.05.034. Epub 2015 Jun 25. Cancer Lett. 2015. PMID: 26118775 Free PMC article.

8

Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest.

Shouse G, de Necochea-Campion R, Mirshahidi S, Liu X, Chen CS. Shouse G, et al. Among authors: chen cs. Oncotarget. 2016 Sep 20;7(38):61081-61092. doi: 10.18632/oncotarget.11209. Oncotarget. 2016. PMID: 27531894 Free PMC article.

9

Aberrant splicing and drug resistance in AML.

de Necochea-Campion R, Shouse GP, Zhou Q, Mirshahidi S, Chen CS. de Necochea-Campion R, et al. Among authors: chen cs. J Hematol Oncol. 2016 Sep 10;9(1):85. doi: 10.1186/s13045-016-0315-9. J Hematol Oncol. 2016. PMID: 27613060 Free PMC article. Review.

10

Application of vitamin D and vitamin D analogs in acute myelogenous leukemia.

Cao H, Xu Y, de Necochea-Campion R, Baylink DJ, Payne KJ, Tang X, Ratanatharathorn C, Ji Y, Mirshahidi S, Chen CS. Cao H, et al. Among authors: chen cs. Exp Hematol. 2017 Jun;50:1-12. doi: 10.1016/j.exphem.2017.01.007. Epub 2017 Feb 4. Exp Hematol. 2017. PMID: 28174131 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,380 results

Search Page